Graphite Bio LENZ
As reported in the Original Form 8-K, effective as of August 21, 2023, Josh Lehrer, M.D.
- Form
- 8-K/A
- Filed
- Period
- Importance
- Notable
- Accession
- 0000950170-23-047925
- Document
- 8-K/A
- Reports an executive or board change (5.02)
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2836) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.
- ImmunityBio IBRX public float $690M, Jun 30, 2025
- Vir Biotechnology VIR public float $689M, Jun 30, 2025
- Anavex Life Sciences AVXL public float $708M, Mar 31, 2025, over 18 months old
- Relay Therapeutics RLAY public float $586M, Jun 30, 2025
- Ginkgo Bioworks Holdings DNA public float $553M, Jun 28, 2025